XML 36 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
9 Months Ended
Sep. 30, 2016
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2016
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
124,834

 
$
(274,575
)
 
$
366,929

 
$

 
$
217,188

Investing activities:

 

 

 

 

Capital expenditures

 
(9,224
)
 
(3,959
)
 

 
(13,183
)
Acquisition payments, net of cash acquired

 
(50,745
)
 

 

 
(50,745
)
Dividends received from subsidiaries

 
47,621

 

 
(47,621
)
 

Other

 
(257,768
)
 
(335,594
)
 
589,477

 
(3,885
)
Net cash used in investing activities

 
(270,116
)
 
(339,553
)
 
541,856

 
(67,813
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
224,043

 
1,386,397

 
468,890

 
(257,768
)
 
1,821,562

Repayments
(344,804
)
 
(834,688
)
 
(500,879
)
 
(331,709
)
 
(2,012,080
)
Dividends paid by subsidiaries

 

 
(47,621
)
 
47,621

 

Other
(4,073
)
 
(3,494
)
 

 

 
(7,567
)
Net cash (used in) provided by financing activities
(124,834
)
 
548,215

 
(79,610
)
 
(541,856
)
 
(198,085
)
Effect of exchange rate changes on cash and cash equivalents

 

 
1,268

 

 
1,268

Net change in cash and cash equivalents

 
3,524

 
(50,966
)
 

 
(47,442
)
Cash and cash equivalents at the beginning of period

 
38,963

 
121,316

 

 
160,279

Cash and cash equivalents at the end of period
$

 
$
42,487

 
$
70,350

 
$

 
$
112,837

 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2015
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(3,332
)
 
$
160,270

 
$
19,026

 
$

 
$
175,964

Investing activities:

 

 

 

 

Capital expenditures

 
(12,137
)
 
(4,105
)
 

 
(16,242
)
Acquisition payments, net of cash acquired

 
(68,502
)
 

 

 
(68,502
)
Dividends received from subsidiaries

 
98,455

 

 
(98,455
)
 

Other

 
(192,781
)
 
14,887

 
179,685

 
1,791

Net cash used in investing activities

 
(174,965
)
 
10,782

 
81,230

 
(82,953
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
157,422

 
936,352

 
394,905

 
(192,781
)
 
1,295,898

Repayments

 
(901,448
)
 
(313,806
)
 
13,096

 
(1,202,158
)
Equity activities
(154,090
)
 

 

 

 
(154,090
)
Dividends paid by subsidiaries

 

 
(98,455
)
 
98,455

 

Other

 
(12,938
)
 

 

 
(12,938
)
Net cash provided by (used in) financing activities
3,332

 
21,966

 
(17,356
)
 
(81,230
)
 
(73,288
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(15,190
)
 

 
(15,190
)
Net change in cash and cash equivalents

 
7,271

 
(2,738
)
 

 
4,533

Cash and cash equivalents at the beginning of period

 
32,508

 
95,811

 

 
128,319

Cash and cash equivalents at the end of period
$

 
$
39,779

 
$
93,073

 
$

 
$
132,852